Global Nuclear Medicine Supply, Demand and Key Producers, 2026-2032
Description
The global Nuclear Medicine market size is expected to reach $ 12050 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032).
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report studies the global Nuclear Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine total market, 2021-2032, (USD Million)
Global Nuclear Medicine total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Nuclear Medicine Market, Segmentation by Type:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Global Nuclear Medicine Market, Segmentation by Application:
Oncology
Thyroid
Cardiology
Others
Companies Profiled:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Key Questions Answered
1. How big is the global Nuclear Medicine market?
2. What is the demand of the global Nuclear Medicine market?
3. What is the year over year growth of the global Nuclear Medicine market?
4. What is the total value of the global Nuclear Medicine market?
5. Who are the Major Players in the global Nuclear Medicine market?
6. What are the growth factors driving the market demand?
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
Market Drivers
The nuclear medicine market is experiencing significant growth due to the increasing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, which require advanced diagnostic and therapeutic solutions. Nuclear medicine provides highly targeted treatment, such as radioisotope therapy, and is crucial for precise imaging techniques like PET and SPECT, which offer better disease detection and management. Advances in radiopharmaceuticals, such as the development of new radioisotopes, and the rising demand for personalized medicine further fuel the market's expansion. Additionally, the growing emphasis on early diagnosis and treatment monitoring in healthcare systems, along with the availability of funding for research and development in nuclear medicine, contributes to market growth.
Market Challenges
Despite its advantages, the nuclear medicine market faces challenges related to the high costs of nuclear medicine treatments and imaging technologies. The infrastructure required for nuclear medicine, including specialized facilities, trained professionals, and the availability of radiopharmaceuticals, can be prohibitively expensive, especially in developing regions. Additionally, concerns over the safe handling and disposal of radioactive materials, regulatory hurdles, and the relatively short half-life of certain isotopes create logistical difficulties in terms of production, distribution, and patient access. These challenges can limit the widespread adoption of nuclear medicine, particularly in low-resource healthcare settings.
This report studies the global Nuclear Medicine demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Nuclear Medicine, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Nuclear Medicine total market, 2021-2032, (USD Million)
Global Nuclear Medicine total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Nuclear Medicine total market, key domestic companies, and share, (USD Million)
Global Nuclear Medicine revenue by player, revenue and market share 2021-2026, (USD Million)
Global Nuclear Medicine total market by Type, CAGR, 2021-2032, (USD Million)
Global Nuclear Medicine total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Nuclear Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cardinal Health, GE Healthcare, Jubilant Pharma, Novartis, Curium Pharma, SIEMENS, Lantheus, Bracco Imaging, Bayer, Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Nuclear Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Nuclear Medicine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Nuclear Medicine Market, Segmentation by Type:
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Global Nuclear Medicine Market, Segmentation by Application:
Oncology
Thyroid
Cardiology
Others
Companies Profiled:
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Yantai Dongcheng
Key Questions Answered
1. How big is the global Nuclear Medicine market?
2. What is the demand of the global Nuclear Medicine market?
3. What is the year over year growth of the global Nuclear Medicine market?
4. What is the total value of the global Nuclear Medicine market?
5. Who are the Major Players in the global Nuclear Medicine market?
6. What are the growth factors driving the market demand?
Table of Contents
112 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Nuclear Medicine Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
